ProtoKinetix Inc.

[On Demand]
Search General Info
Search Education
Search Partnering Companies
ProtoKinetix is a research and development company leading the way in cell survival solutions. AAGP®, our patented anti-aging glycopeptide, is a revolutionary discovery with incredible opportunity to shape the future of ophthalmology, dermatology, transplant support and biomanufacturing.

Based on a molecule found in nature and harnessed by a world-class research team, this anti-aging glycopeptide keeps more cells alive longer. It utilizes the same properties that help animals survive in arctic temperatures, and it has the capability to change regenerative medicine forever.

With AAGP®, health therapies will become more effective, more affordable and more accessible. We will get closer to cures for conditions such as Type 1 diabetes, macular degeneration, heart disease and stroke. More lives will improve, and more people will get the treatments they deserve.
Ticker:
PKTX
Exchange:
OTC
Company Type:
Publicly Traded Company
Company HQ State:
Ohio
Company HQ Country:
United States
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
PKX-001
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3
Speaker
photo
Chief Scientific Officer
NBBM Inc.